GLP-1 insurance coverage
Sometimes. Most provincial drug plans pay for Ozempic only for type 2 diabetes, and only after special authorization or Limited Use criteria are met. The public plans we confirmed for Wegovy, British Columbia and Ontario, do not pay for weight management, and private plans vary by employer.
Coverage
Ontario Drug Benefit · Ozempic
Partial coverageLimited Use (LU 665, 666, 667): type 2 diabetes when metformin at the maximum tolerated dose hasn't controlled blood sugar, or isn't suitable. Not funded otherwise.BC PharmaCare · Ozempic
Partial coverageSpecial Authority: type 2 diabetes after inadequate control on maximum tolerated metformin. Covered up to a 1 mg weekly pen; the 2 mg dose is under review.BC PharmaCare · Wegovy
Not coveredNon-benefit: PharmaCare decided not to cover Wegovy after national price negotiations ended without agreement.Ontario Drug Benefit · Wegovy
Not coveredListed as Off-Formulary Interchangeable since 31 Aug 2026. The record shows no amount paid by the Ministry of Health.Ontario Drug Benefit (generic semaglutide) · Ozempic
Partial coverageApo-Semaglutide (DIN 02568020, 02568012) and Dr. Reddy's Semaglutide Injection (02567806, 02567814) listed 30 Jun 2026 as interchangeable with Ozempic under its Limited Use criteria.Ontario Drug Benefit · Rybelsus
Partial coverageLimited Use (LU 738, 739, 740 for 1.5 mg, 4 mg, 9 mg tablets): adult type 2 diabetes not controlled on maximum tolerated metformin, or metformin contraindicated or inappropriate. Not funded with injectable semaglutide.Ontario Drug Benefit (Sevmia) · Wegovy
Not coveredSevmia 4mg/3mL (DIN 02569582, Apotex) listed 31 Aug 2026 as an Off-Formulary Interchangeable of Wegovy: substitutable by pharmacists, not a formulary benefit.Alberta Drug Benefit List · Ozempic
Partial coverageSpecial authorization: add-on therapy in type 2 diabetes after sufficient trial (such as 6 months) of metformin and a sulfonylurea, where insulin is not an option; may be granted for 24 months.Alberta Blue Cross employer plans · Wegovy
Partial coverageWeight-loss special authorization form for employer plans; max two trials per drug per lifetime; request may or may not be approved.Alberta Blue Cross employer plans · Zepbound
Partial coverageWeight-loss special authorization form for employer plans lists Zepbound; max two trials per drug per lifetime; request may or may not be approved.Manitoba Pharmacare · Ozempic
Partial coverageOn the list of drugs with indefinite Exception Drug Status approval, effective 21 Jan 2021; individual EDS application by prescriber.Nova Scotia Pharmacare · Ozempic
Partial coverageException Status benefit (E): type 2 diabetes with metformin and a sulfonylurea; max 1 prefilled pen every 4 weeks.PEI Pharmacare · Ozempic
Partial coverageSpecial authorization for semaglutide: type 2 diabetes with metformin (6 months) and a sulfonylurea; max 1 prefilled pen every 4 weeks.Canada Life employer plans · Wegovy
Partial coveragePrior authorization form; Wegovy not covered under all benefit plans; asks for 3-6 months of unsuccessful diet/exercise and a BMI threshold.
How public and private drug coverage work
Drug coverage in Canada comes from two places. Each province runs a public drug plan, and many people also have a private plan through an employer or an insurer. A public plan pays for drugs on its formulary, the list of drugs the plan agrees to pay for. A drug can be on the list in full, on the list with conditions, or off the list.
A drug listed with conditions is the case for most GLP-1 products. Your prescriber has to show that you meet the conditions before the plan pays. Plans call this special authorization, Limited Use, Exception Drug Status or Special Authority. In every one of those, your prescriber sends the plan details of your diagnosis and past treatment first.
We mark that case as partial, never covered, because a request can be refused.
Why weight management is rarely covered publicly
Ozempic and Wegovy both contain semaglutide, but Health Canada approves them for different uses. Ozempic is approved for type 2 diabetes. Wegovy is approved for chronic weight management. Public plans list Ozempic against the diabetes use, and the criteria we read all name type 2 diabetes and ask about metformin first.
For Wegovy, the national drug review body (CDA-AMC) recommended reimbursement only with conditions: adults with a body mass index of 27 or higher and established cardiovascular disease, and only if the price is reduced. BC’s PharmaCare decision of 18 December 2025 says negotiations between the pan-Canadian Pharmaceutical Alliance and the manufacturer ended without agreement, and it lists Wegovy as a non-benefit.
Ozempic coverage by province
The table on this page lists each plan and drug we have confirmed from the plan’s own documents, with the document date and a link to it. Read the rule column, not just the status.
The wording differs by province but the pattern is the same. Plans ask for a type 2 diabetes diagnosis, usually after metformin, and some also ask about a sulfonylurea or whether insulin is an option. A few cap the supply, for example one pen every four weeks. Check the date on each row, because plan criteria change.
Some provinces are not in the table yet. We haven’t confirmed Saskatchewan, Newfoundland and Labrador, Quebec or New Brunswick from a current plan document, so we state nothing about them. Ontario has its own page: see Ontario coverage.
What about Mounjaro, Zepbound and Saxenda?
We haven’t confirmed public coverage positions for tirzepatide (Mounjaro and Zepbound) or liraglutide (Saxenda) in any province. The provincial pages we read name semaglutide only, and we won’t guess for the others. Ask your pharmacist to run the drug against your plan, or check your plan’s drug list.
Private and employer plan coverage
Private plans set their own rules, and the same insurer can cover a drug for one employer and not another. Two published examples show what a plan can ask for.
Canada Life’s prior authorization form for Wegovy states that Wegovy is not covered under all benefit plans and asks the patient to confirm coverage before the request is sent. It asks whether the patient has tried diet and exercise for at least 3 to 6 months and checks a body mass index threshold.
Alberta Blue Cross has a weight-loss special authorization form for employer plans that names Saxenda, Contrave, Wegovy and Zepbound. It allows a maximum of two trials per drug per lifetime, and it says a request may or may not be approved.
Your plan booklet or the insurer’s member site is the only way to know what your plan does. Ask whether the drug needs prior authorization, which products it accepts, and whether there is a yearly or lifetime limit.
What to do next
- Find your plan’s drug list or call the number on your card, and ask whether your drug needs approval first.
- Ask your prescriber to send the request with your diagnosis and past treatments.
- Ask your pharmacist for the full price with the dispensing fee, so you know what you would pay if the request is refused. See our price pages.
- If you want a prescriber online, see how the provider models differ.
- For the Ontario rules, see our Ontario guide.
Questions people ask
Does any province cover Wegovy for weight management?
We haven't found one. British Columbia's PharmaCare decision of 18 December 2025 lists Wegovy as a non-benefit, and Ontario's formulary treats Wegovy as off-formulary. We haven't confirmed the other provinces' Wegovy positions yet.
What is special authorization?
It is a step where your prescriber sends your drug plan a form showing you meet the plan's conditions before it will pay for a drug. Plans use different names, such as Limited Use, Exception Drug Status or Special Authority.
Can a private plan cover Ozempic or Wegovy?
Some employer plans do, usually with prior authorization. Canada Life's Wegovy form says Wegovy is not covered under all benefit plans, so check yours before you fill a prescription.
Why is Ozempic covered for diabetes but not weight loss?
Ozempic is approved by Health Canada for type 2 diabetes, and plans list it for that use. Wegovy, the semaglutide product approved for chronic weight management, has not been listed by the public plans we checked.
Does generic semaglutide change coverage?
In Ontario, two generic semaglutide products are listed under the same Limited Use rules as Ozempic. Other provinces decide separately.